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Abstract
Background: Neuregulin1 (NRG1)-ErbB signaling has been implicated in the pathogenesis of cancer and schizophrenia. We
have previously reported that NRG1-stimulated migration of B lymphoblasts is PI3K-AKT1dependent and impaired in
patients with schizophrenia and significantly linked to the catechol-o-methyltransferase (COMT) Val108/158Met functional
polymorphism.
Methodology/Principal Findings: We have now examined AKT1 activation in NRG1-stimulated B lymphoblasts and other
cell models and explored a functional relationship between COMT and AKT1. NRG1-induced AKT1 phosphorylation was
significantly diminished in Val carriers compared to Met carriers in both normal subjects and in patients. Further, there was a
significant epistatic interaction between a putatively functional coding SNP in AKT1 (rs1130233) and COMT Val108/158Met
genotype on AKT1 phosphorylation. NRG1 induced translocation of AKT1 to the plasma membrane also was impaired in Val
carriers, while PIP3 levels were not decreased. Interestingly, the level of COMT enzyme activity was inversely correlated with
the cells’ ability to synthesize phosphatidylserine (PS), a factor that attracts the pleckstrin homology domain (PHD) of AKT1
to the cell membrane. Transfection of SH-SY5Y cells with a COMT Val construct increased COMT activity and significantly
decreased PS levels as well as NRG1-induced AKT1 phosphorylation and migration. Administration of S-adenosylmethionine
(SAM) rescued all of these deficits. These data suggest that AKT1 function is influenced by COMT enzyme activity through
competition with PS synthesis for SAM, which in turn dictates AKT1-dependent cellular responses to NRG1-mediated
signaling.
Conclusion/Significance: Our findings implicate genetic and functional interactions between COMT and AKT1 and may
provide novel insights into pathogenesis of schizophrenia and other ErbB-associated human diseases such as cancer.
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Introduction
Neuregulin1 (NRG1)-ErbB signaling has been implicated in the
pathogenesis of cancer and schizophrenia. In recent work using a
B lymphoblast cell model, we showed that these cells express a
functional ErbB signaling pathway, and that NRG1 promotes
their adhesion and migration [1,2]. Using this cell system, we
found that NRG1-stimulated cell adhesion and migration were
impaired in patients with schizophrenia [1,2]. Further, we
demonstrated that the COMT Val158Met polymorphism, which
alters COMT enzyme activity [3,4,5], predicts the adhesive and
migratory responses of these cells to NRG1 in both normal
subjects and in patients and that the group of patients with the
high-activity Val allele was the most relatively impaired. Because
NRG1-mediated adhesion and migration is PI3K-AKT1depen-
dent [1,2], the findings from our previous studies led us to
hypothesize that there may be a functional relationship between
COMT and AKT1. Interestingly, both COMT and AKT1 have
also been implicated in the pathogenesis of cancer and
schizophrenia, and their associations with these disease conditions
have been extensively studied [4,6].
COMT catalyzes the transfer of the methyl group of S-
adenosylmethionine (SAM) to a hydroxyl group on a variety of
catechols, including the catecholamine neurotransmitters and
carcinogenic catechol estrogen compounds [4]. A G to A transition
(rs4680) at COMT codon 108/158 translates a valine to methionine
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proteins, respectively [3,4]. A number of studies have shown that the
high activity Val allele is associated with relatively poorer function of
prefrontal cortex, compared with the Met form [7,8,9,10,11]. While
results have been inconsistent, the Val allele has also been
occasionally implicated as a risk factor for schizophrenia [7,12].
Similarly, some studies have also shown an association of Val108/
158Met with breast cancer [13,14,15,16,17,18] and prostate cancer
[19]; the low activity Met allele is often associated with increased risk
of metastasis and poorer prognosis. Recent evidence indicates that
there are other functional variants in COMT that modulate the
biologic effects of the Val/Met polymorphism and confound simple
Val/Met associations [20,21].
AKT1 is a serine/threonine kinase that functions as a central
element in the cell survival pathway and is activated in many
cancers [22]. Recently, a Glu to Lys mutation at amino acid 17 of
the AKT1coding sequence has been identified in breast, colon and
ovarian cancers, suggesting that this mutation may cause 2-8% of
cancers of these types [23]. The AKT1 gene has also been
associated with schizophrenia. Emamian and colleagues [24]
demonstrated reduced AKT1 protein expression in B lympho-
blasts and postmortem brain tissues from patients with schizo-
phrenia. They also provided the first evidence of association
between AKT1 and schizophrenia in Caucasians based on 5 SNPs
spanning this gene. At least six subsequent studies [24,25,26,27,28]
and one-meta analysis [29] have provided supportive evidence for
this association. Further, a coding and risk-associated polymor-
phism (rs1130233) has been associated with low expression of the
protein and increased susceptibility to apoptosis in B lymphoblasts
[30,31]. AKT1 also has been implicated in dopamine signaling in
brain [32,33], and a recent imaging study of normal subjects
suggested that COMT and AKT1 interact at the level of cortical
physiology related to dopamine function [31].
Despite the overlap of COMT and AKT1 in associations with
cancer and schizophrenia, molecular and cell biological interac-
tions of COMT and AKT1 have not been explored. In the present
study, using NRG1-ErbB signaling in the B lymphoblast cell
system and in other cell models, we show evidence of epistatic
effects between these genes in that COMT Val/Met affects AKT1
translocation and activation by competing for methyl donor
availability required for PS synthesis. Our findings provide a
potential mechanism for the impact of COMT on NRG1-induced
adhesion and migration and also possibly for the association of
these genes with schizophrenia and cancer.
Results
Effects of the COMT Val/Met polymorphism on
NRG1-stimulated phosphorylation of AKT1
We previously demonstrated an association between COMT
Val/Met (rs4680) genotype and NRG1-mediated adhesion and
migration [1,2]. Because NRG1-mediated adhesion and migration
are PI3K/AKT1 signaling-dependent, we sought to determine if
NRG1-induced activation of AKT1 was also associated with
COMT genotype. Activation of AKT1 depends on its phosphor-
ylation at Thr-308 in the catalytic domain and Ser-473 in the C
terminus. In B lymphoblasts, NRG1 significantly induced a Ser-
473 phosphorylation of AKT1 that persisted for at least 1 hour,
whereas total AKT1 levels remained unchanged. Therefore, we
measured peak fold increases in the Ser-473 phophorylated-
AKT1/total AKT1 ratio over baseline during one hour of NRG1-
stimulation. Using this assay, we found a significant effect of
COMT genotype on NRG1-stimulated Ser-473 phosphorylation
of AKT1 (Figure 1). Thus, consistent with our earlier preliminary
findings [1,2], NRG1-stumulated increases in AKT1phosphoryla-
tion were significantly decreased in Val homozygotes, compared
with Met homozygotes (p=0.0024) and this was unaffected by
diagnosis (Figure 1).
Epistatic effects of COMT Val/Met and AKT1 rs1130233
on NRG1-stimulated phosphorylation of AKT1
To confirm whether a functional polymorphism within the
AKT1 gene is associated with the expression and function of
AKT1 and might interact epistatically with COMT, we genotyped
64 B lymphoblast lines for the coding SNP rs1130233 previously
found to affect AKT1 protein levels and radiation induced
apoptosis [30]. AKT1 rs1130233 genotype was in Hardy-
Weinberg equilibrium (Fisher’s exact test p-values .0.05) and
showed a minor allele frequency (MAF) similar to that reported
previously for Caucasian populations (Supplementary Informa-
tion, Fig. S1 online). Consistent with earlier studies [24,30,31], we
also confirmed that levels of AKT1 protein, assessed by Western
blot and displayed as AKT1/b-actin ratios, were significantly
lower in heterozygotes (G/A) compared with G/G homozygotes
(p=0.006) (Figure 2).
In contrast to the association with protein levels, rs1130233
genotype showed no association with NRG1-stimulated phos-
phorylation of AKT1 in the entire sample (Figure 2D) and no
interaction with disease status (Figure 2E), but it did interact
epistatically with COMT Val/Met genotype (Figure 2F). A two-
way ANOVA revealed a significant interaction between AKT1
rs1130233 genotype and COMT Val/Met genotype (F(1,
25)=5.83, p=0.0234) on NRG1-induced Ser-473 phosphoryla-
tion of AKT1(Figure 2F). Post-hoc tests showed that the
interaction was due to a significant rs1130233 genotype effect on
NRG1-induced Ser-473 phosphorylation of AKT1 only in
individuals who were COMT Met/Met homozygotes
(P=0.0182), likely because Val/Val individuals had markedly
reduced phosphorylation of AKT1 regardless of rs1130233
genotype. We found no interaction for AKT1 protein levels
(Figure 2C).
Effect of increasing COMT activity on AKT1
phosphorylation
The COMT Val/Met polymorphism is associated with variable
enzyme activity: the Val allele encodes an enzyme with higher
activity than the Met form [3,5]. Therefore, we hypothesized that
decreases in NRG1-stimulated AKT1 phosphorylation in COMT
Val homozygote lymphoblasts were due to high COMT activity.
To determine the effect of increasing activity of COMT on AKT1
phosphorylation, we overexpressed the Val form of COMT in SH-
SY5Y cells. The overexpressed COMT transcript was tagged with
GFP, allowing us to monitor transfection efficiency by measuring
GFP positive cells using fluorescence microscopy (Figure 3A). We
maintained consistently high transfection efficiency, which was
between 70% and 80%. In these transfected cells, we confirmed
expression of GFP-tagged COMT protein as well as endogenous
membrane-bound (MB) and soluble (S) forms of COMT protein
by Western blot (Figure 3B). We found a five-fold increase in
COMT activity in these cells, compared with those transfected
with control vector, and demonstrated the specificity of the
enzyme activity assay by showing that measurement of COMT
activity was almost completely blocked by the addition of the
specific COMT inhibitor tolcapone (Figure 3C).
SH-SY5Y cells express ErbB2, 3 and 4 receptors and activate
typical tyrosine receptor signaling cascades in response to NRG1-
stimulation, such as a PIP3-AKT1 signaling cascade (unpublished
Epistasis between COMT & AKT1
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AKT1phosphorylation that persisted for at least 60 min in SH-
SY5Y cells transfected with a control vector containing GFP only.
In contrast, NRG1-stimulated phosphorylation of AKT1 was
significantly reduced in COMT transfected cells (Figure 3D).
Repeated measures ANOVA showed a significant main effect of
COMT transfection on AKT1phosphorylation (F3,12=19.91,
p=0.0017) (Figure 3D).
COMT Val/Met genotype and translocation of PHD-AKT1
in B lymphoblasts
PIP3-triggered translocation of AKT1 from the cytoplasm to the
plasma membrane is a prerequisite for its phosphorylation and
activation [34]. To examine this process in cells, we constructed a
vector containing fluorescence–tagged PHD-AKT1 (pEYFP-ph-
AKT) and developed a method to evaluate translocation using B
lymphoblasts transfected with this construct. B lymphoblasts from
8 control individuals were used for this test (Figures 4A and B).
PHD-AKT1 translocation was examined using fluorescence
microscopy 24 hours after transfection, before and after stimula-
tion with NRG1. Firstly, we found a significant positive correlation
between NRG1-stimulated translocation and NRG1-stimulated
Ser-473 phosphorylation of AKT1 (phosphorylated-AKT1/total
AKT1ratio)(r=.832, p=0.0075) (Figure 4A), consistent with the
notion that NRG1-stimulated phosphorylation depends on the
translocation of AKT1. Secondly, we found that NRG1-
stimulated translocation was significantly lower in Val homozy-
gotes than in Met homozygotes (p=0.029) (Figure 4B). These
results suggest that the difference in NRG1-stimulated Ser-473
phosphorylation between Val and Met homozygotes is due to
differences in AKT1translocation.
COMT, phosphatidylserine and PIP3 in B lymphoblasts.
Although PS has no direct effect on AKT1 activity [35], it has
been implicated as playing a role in PIP3-induced full AKT1
activation since the translocation of AKT1 may require the
interaction of PHD-AKT1with membrane PIP3 and PS [36]. For
this reason, we studied the status of PIP3 and PS in the B
lymphoblasts. PS levels in B lymphoblasts from 25 subjects were
measured after 16 hr of serum-deprivation and compared with
those from cells fed normally. The serum deprivation, which
removes exogenous PS, PC and cholines, reduced PS levels (paired
t-test, mean diff; 212.015, p,0.0001). However, the degree of the
reduction varied widely depending on the subject. Thus, the ratio
of PS levels in serum-deprived condition/PS level in the non-
deprived condition, a measure of PS synthetic capacity, from 25
subjects ranged between 0.3 and 1.0. These ratios were inversely
correlated with COMT enzyme activity measured in the same
lymphoblast lines (r=2.622, p=0.0006) (Figure 4C). The higher
the COMT activity cells possess, the greater the accompanying
reduction in PS synthetic capacity. This result suggests a functional
relationship between COMT activity and the cells’ ability to
synthesize PS.
Another potential mechanism for the poor NRG1-stimulated
phosphorylation of AKT1associated wtih COMT Val genotype or
high enzyme activity might be reduced PIP3 generation. However,
NRG1-stimulated PIP3 generation was not diminished (Supplemen-
tary Information, Fig. S2 online). Wald-Wolfowitz Runs Test
indicated no significant effect of COMT Val/Met genotype on
Figure 1. Effects of COMT Val/Met genotype and disease on NRG1-stimulated Ser-473 phosphorylation of AKT1in B lymphoblasts
derived from controls and patients with schizophrenia. (A) COMT Val/Meet genotype and NRG1-stimulated Ser-473 phosphorylation of AKT1.
NRG1-stumulated increases in AKT1 phosphorylation in B lymphoblasts were significantly decreased in Val homozygotes (n=18), compared with Met
homozygotes (n=12) (p=0.0024, t-test). The Y-axis shows the peak fold increases in the phosphorylated-AKT1/total AKT1 ratio during one hour
stimulation. (B) Disease and and NRG1-stimulated phosphorylation of AKT1. There was no difference in NRG1-stumulated increases in AKT1
phosphorylation in B lymphoblasts between controls (n=16) and patients with schizophrenia (n=14). (C) COMT Val homozygotes had significantly
lower NRG1-stimulated phosphorylation of AKT1 in both controls (P=0.029) and patients with schizophrenia (p=0.042, t-test).
doi:10.1371/journal.pone.0010789.g001
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effect of AKT1 rs1130233 genotype (P=0.6488) and no interaction.
Effects of high COMT activity on NRG1-stimulated
translocation of PHD-AKT1 and PIP3 generation in
SH-SY5Y cells
To further determine if effects of COMT Val/Met genotype on
NRG1-stimulated translocation of PHD-AKT1 in B lymphoblasts
is due to COMT enzyme activity, we performed an AKT1
translocation experiment using the COMT-transfected SH-SY5Y
cell model. pDsRed-ph-AKT was used for this experiment since
COMT was tagged with GFP. Our examinations of fluorescence
signals confirmed that there was no overlapping signal from green
(GFP) and red (pDsRed) fluorescence, indicating that the
localization of red fluorescence reflected accurately the localization
of PHD-AKT1 expressed in the transfected cells. Approximately
48 hours after double-transfection with either pDsRed-ph-AKT
plus pAcGFP-N1-COMT or pDsRed-ph-AKT plus control vector,
the cells were stimulated with NRG1 and terminated by fixation
buffer at different time points. This time-course study indicated that
stimulation with NRG1 produced PHD-AKT1 localization, which
was observed as fluorescence distribution patterns of multiple spots,
clusters or broad membranous distribution (Figure 5A). The results
from three independent experiments showed that the proportion of
cells with homogenous distribution (i.e., no translocation) was
significantly lowered after NRG1 treatment in the cells transfected
with control vector compared to the COMT transfected cells,
suggesting that NRG1-stimulated translocation of PHD-AKT1 in
COMT-transfected cells was significantly suppressed compared to
the cells transfected with control-vector. A two-way ANOVA
showed a significant interaction between NRG1-treatment and
COMT-transfection for the NRG1-induced changes in proportion
of cells with homogenous distribution (i.e., no translocation)
(F(1,12)=10.34, p=0.0074) (Figure 5A). The NRG1-induced
increases in the cells showing clusters and broad membranous
Figure 2. Effects of AKT1 rs1130233 on AKT1 protein expression and NRG1-stimulated Ser-473 phosphorylation of AKT1in B
lymphoblasts derived from controls and patients with schizophrenia. (Upper panel; A, B and C) Effects of AKT1 rs1130233 on AKT1 protein
expression. The minor rs1130233 allele was associated with lower expression of AKT1 protein (AKT1/b-actin ratio, mean6SE). p=0.006, rs1130233 G/A
vs. G/G; p=0.0406. The associations were preserved in both control and patient groups (B), similarly in COMT Val/Val and Met/Met groups (C). Within
the rs1130233 G/A group (C), AKT1protein expression was significantly decreased in individuals with Val carriers compared with Met carriers.
p=0.0371, rs1130233 G/A, Val vs. G/A, Met. The number of subjects carrying [G/G, Val], [G/G, Met], [G/A, Val] and [G/A, Met] genotype was 18, 12, 10
and 16, respectively. (Lower panel; D, E and F) Effects of AKT1 rs1130233 on NRG1-stimulated phosphorylation of AKT1. AKT1 rs1130233 had no effect
on this phenotype in the total population (D) and no interaction with disease on the phenotype (E). Two-way ANOVA showed significant main effects
of AKT rs1130233 genotype (P =0.0066), significant main effect of COMT genotype (p=0.0003) and significant interactions of these genotypes
(p=0.0234) on NRG1-induced phosphorylation. In individuals who were also COMT Met/Met homozygotes, individuals carrying the AKT1 S rs1130233
minor A allele, showed significantly lower phosphorylation than G/G carriers (P=0.0182). This effect was not appeared in Val/Val individuals because
of the maximum reductions in AKT1 phosphorylation.
doi:10.1371/journal.pone.0010789.g002
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COMT and control vector-transfected cells. There were significant
interactions between NRG1-treatment and COMT-transfection for
those two categories (F(1, 12)=5,44, p=0.0379 for clustering and
F(1,12)=5.31, p=0.0398 for membranous distribution) (Figure 5A).
These results from the PHD-AKT1 translocation experiments
suggested that significant reductions in NRG1-stimulated Ser-473
phosphorylation in the COMT-transfected cells was due at least in
part to poor AKT1 translocation.
We then studied NRG1-stimulated PIP3 generation to deter-
mine if the poor NRG1-stimulated translocation and phosphor-
ylation of AKT1 by the COMT transfection is due to reduced
PIP3 generation. However, there was no difference in NRG1-
stimulated PIP3 generation between the COMT- and control
vector-transfected cells in two measures from three independent
transfection experiments: summation of changes (P=0.5782) and
peak folds (p=0.6134) (Figrure 5B). These results from the SH-
SY5Y transfection system were consistent with those from B
lymphoblasts.
Effects of COMT on AKT1 activation and PS levels are
reversed by SAM
PS synthesis is regulated by constitutively active methylation of
phospholipids [37]. The enzymes PEMT, PSS1 and PSS2 are
responsible for maintaining the balance of PE, PC and PS,
particularly when PC and PE are in limited exogenous supply
[37]. We hypothesized that the reductions in AKT1phosphoryla-
tion and PS synthesis caused by COMT transfection may be
mediated by a disruption of phospholipid methylation. This is a
Figure 3. Effects of COMT transfection on COMT activity and NRG1-stimulated Ser-473 phosphorylation of AKT1 in SH-SY5Y cells.
SH-SY5Y cells were transfected with COMT-GFP or with the control GFP vector. After 48 hrs, cells were analyzed for enzyme activity and expression of
COMT and tested for Ser-473 phosphorylation of AKT1 in response to NRG1a. (A) GFP-detection after transfection of GFP-tagged COMT or control
GFP vector showed 70–80% transfection efficiency. (B) Expression of the transfected COMT. Western blotting showed expression of a 60-kDa band,
representing GFP-tagged human MB-COMT in cells transfected with COMT-GFP (left three lanes). Endogenous 30-kDa MB- and 25-kDa S- COMT
proteins were expressed under both transfection conditions. (C) Effects of COMT transfection on COMT enzyme activities. The COMT enzyme assay
indicated a significant five-fold increase in COMT activity (dpm per mg total protein) in cells transfected with COMT-GFP compared to cells
transfected with control vector. *p,0.0001, 3 samples per group. The specificity of the assay was confirmed by a complete attenuation of the enzyme
activity by 100 mM of the specific COMT inhibitor tolcapone. (D) Effects of COMT transfection on NRG1a-stimulated Ser-473 phosphorylation of AKT1
in SH-SY5Y cells. At 48 hrs after transfection, the transfected cells were stimulated with NRG1a (100 ng/ml) for the time points indicated. Protein
isolated from the cells was analyzed by Western blotting. To quantify the level of phosphorylation, the immunoblots were stained with antibodies
specific to phosphorylated AKT1- at Ser-473 and were then stripped and reprobed with antibodies to total AKT1. The bar graphs represent changes in
the ratio of phosphorylated form to total AKT1 (means6SEM, from 3 transfection experiments). A repeated measure ANOVA showed a significant
main effect of COMT transfection on AKT1 phosphorylation (P=0.0017).
doi:10.1371/journal.pone.0010789.g003
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adenosylmethionine; SAM) as COMT. Therefore, COMT activity
might indirectly impact on the function of PEMT (and vice versa)
due to competition for SAM. If this is the case, the effect of
COMT on AKT1phosphorylation and on PS synthesis should be
reversible by SAM supplementation. Indeed, in the COMT-
transfected SH-SY5Y cells, SAM treatment reversed the inhibitory
effect of COMT transfection on NRG1-stimulated phosphoryla-
tion of AKT1 (Figure 6A), supporting this hypothesis. The ratio of
phosphorylated/total AKT1 at 60 min after the stimulation was
significantly increased by 1 mM SAM treatment prior to the
stimulation (p=0.0413, vehicle vs. SAM). Using the SH-SY5Y
cells, we also found that COMT transfection decreased total PS
levels significantly; ANOVA revealed a significant effect of COMT
transfection (F(1,7)=38.6, P=0.0004). Further, SAM treatment
significantly reversed the COMT transfection effect on PS
(F(1,10)=10.55, p=0.0087) while there was no interaction
between COMT transfection and SAM treatment (Figures 6B).
These results are consistent with the inverse relationship between
COMT activity and PS synthesis ability seen in B lymphoblasts
(Figure 4C) and also suggest that the increase in COMT activity
reduces PS synthesis and NRG1-stimulated phosphorylation of
AKT1 in a SAM-dependent manner.
Because the neuroblastoma line SH-SY5Y is dopaminergic and
these cells express dopamine receptors, it is conceivable that the
effect of COMT transfection on PS might be mediated by
dopamine in these cells. Therefore, we also tested HEK293 cells,
which normally do not express dopamine receptors [38].
Figure 4. Effects of COMT Val/Met genotype on PHD-AKT1translocation and phospholipid levels in B lymphoblasts derived from
controls and patients with schizophrenia. (A) There was a positive correlation between NRG1-stimulated Ser-473 phosphorylation of AKT1 and
NRG1-simulated PHD-AKT translocation. B lymphoblasts from control subjects were transfected with pEYFP-ph-AKT. At 24 hrs after transfection, PHD-
AKT1 translocation was stimulated with NRG1 for 15 min and measured under the fluorescence microscope. Translocation indexes from 8 control
subjects were positively correlated with NRG1-stimulated peak fold increases in Ser-473 phosphorylation of AKT1 (phophorylated-AKT1/total AKT1
ratio) that were separately obtained from the same individuals (r=.832, p=0.0075). (B) Representative fluorescence microscopic images of PHD-AKT1
fluorescence. Single cell images of PHD-AKT1fluorescence before and after NRG1 stimulation in typical COMT Val/Val and Met/Met homozygotes are
shown. The bar graph represents PHD-AKT1 tranlocation index (means6SEM). *p=0.029, individuals with Val/Val genotype (n=5) vs. Met/Met
genotype (n=5). (C) There was a correlation between COMT enzyme activity and phosphatidylserine (PS) synthesis ability. Y-axis indicates relative
COMT activity (dpm per mg total protein) in the B lymphoblasts. X-axis indicates PS synthesis ability (the ratio of total PS fluorescence intensity of B
lymphoblast after exposure to serum free medium for 24 hrs/PS fluorescence intensity after culturing in normal culture media containing 15% FBS,
which reflects a cell’s ability to maintain PS levels) (see Materials and Methods). COMT enzyme activity was significantly correlated with PS synthesis
ability in total 25 subjects (12 patients and 13 controls) (Total; R=2.622, p=0.0006, patients; R=2.667, p=0.0156 and controls; R=2.634,
p=0.0180).
doi:10.1371/journal.pone.0010789.g004
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that COMT transfection decreased PS to a greater extent than
control vector transfection (p=0.0191, unpaired t-test) (Supple-
mentary Information, Fig. S3 online) and this COMT-induced
reduction in PS was reversed by SAM treatment (Supplementary
Information, Fig. S4 online). In this experiment, we also tested
whether active removal of SAH by SAHH transfection could have
either an additive or synergistic effect with SAM treatment, since
SAH acts as a functional inhibitor of SAM-dependent methyl-
transferases. However, we found no significant effect of SAHH
transfection alone or an interaction between SAHH transfection
with SAM treatment on PS synthesis, suggesting that the effect of
COMT on PS synthesis is mediated by insufficient SAM levels,
rather than excessive SAH accumulation.
Effects of COMT on AKT1 activation are not restricted to
NRG1-ErbB signaling
If the decrease in PS synthesis is the cause, at least in part, for
the poor translocation and phosphorylation of AKT1, the effect of
COMT Val/Met genotype or enzyme activity may not be limited
to NRG1-ErbB signaling. To test this hypothesis, we studied
whether COMT transfection affects ligand-stimulated phosphor-
ylation of AKT1 induced via other signaling pathways, using SH-
SY5Y cells. We used BDNF to stimulate the tyrosine kinase
receptor trkB, and SDF1 and ACEA to stimulate the G-protein
coupled receptors, CXCR4 and the cannabinoid (CB) receptor,
respectively. We also tested the b-isoform of NRG1 to confirm that
the effect of COMT transfection on NRG1-ErbB-mediated
phosphorylation of AKT1is not specific to the a-isoform. Although
the inhibition in ACEA or BDNF-stimulated AKT1phosphoryla-
tion by COMT overexpression was small, COMT over-expression
significantly inhibited SDF1-stimulated phosphorylation of AKT1
(p,0.0005, t-test) (Figure 7). Furthermore, consistent with our
findings for NRG1a, we confirmed significant suppression of
AKT1phosphorylation following stimulation with NRG1b
(P=0.0341) (Figure 7). These results suggest that COMT enzyme
activity, which is related to Val/Met genotype, affects AKT1ac-
tivity stimulated by a variety of ligands, and that the mechanism(s)
for this is dopamine-independent.
Effects of high COMT activity on NRG1-induced migration
of SH-SY5Y cells
Finally, we attempted to determine if high COMT enzyme
activity produces a negative effect on cell migration. Since SH-
Figure 5. Effects of high COMT activity on NRG1-stimulated PHD-AKT1 translocation and PIP3 generation in transfected SH-SY5Y
cells. (A) Effects of high COMT activity on PHD-AKT1translocation. SH-SY5Y cells were double-transfected with either pDsRed-ph-AKT plus COMT or
pDsRed-ph-AKT plus control vector. After 48 hrs, cells were analyzed for PHD-AKT1 translocation in response to NRG1a. The bar graph represents
percent positive cells indicating PHD-AKT1 translocation (means6S.E.) from four transfection experiments. Two-way ANOVA, interaction between
NRG1a treatment and COMT transfection, *p,0.05, **p=0.0074. Lower inset shows representative fluorescence microscopic images of PHD-AKT1
fluorescence in a single cell. From left, untranslocated homogenous distribution of PHD-AKT1, translocated PHD-AKT1 as spots, clusters and broad
membranous distributions. (B) Effects of high COMT activity on NRG1-stimulated PIP3 generation. SY5Y cells were transfected with either COMT or
control vector. The cells were analyzed for NRG1-stimulated PIP3 generation using flow cytometry. Top panel indicates a summation of positive and
negative changes in PIP3 during a 30 min observation period and lower panel indicates peak folds of PIP3 during a 30 min period.
doi:10.1371/journal.pone.0010789.g005
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dependent manner, the SH-SY5Y-COMT transfection system is
suited for this experiment. As expected in untransfected SH-SY5Y
cells, our migration assay using a transwell chamber showed a
positive NRG1-stimulated migration in control-vector transfected
cells (Figure 8). In contrast, COMT transfection significantly
decreased NRG1-stimulated migration compared to the transfec-
tion with a control empty vector (p=0.0165, unpaired t-test)
(Figure 8). Further, SAM treatment significantly rescued the
COMT transfection effect on migration (Figure 8). Repeated
measures ANOVA revealed a significant main effect of SAM
treatment (F1, 12=7.30, P=0.0193) and a significant interaction
between COMT transfection and SAM treatment (F1, 12=8.18,
p=0.0144). These results are consistent with the effect of COMT
Val/Met genotype on NRG1-stimulated migration seen in B
lymphoblasts [2] and therefore suggest that the increase in
COMT activity reduces migration ability in a SAM-dependent
manner.
Discussion
In the present study, we have found that the valine allele of
COMT is associated with diminished NRG1-induced AKT1
phosphorylation in B lymphoblasts from both controls and
patients, and showed that COMT overexpression in SH-SY5Y
cells led to impaired AKT1 phosphorylation and migration in
response to NRG1. These results suggest that the relatively poorer
NRG1-induced adhesion and migratory response seen in Val
homozygote lymphoblasts [2] is due, at least in part, to reduced
activation of AKT1. In addition, we have demonstrated a
plausible mechanism by which the effect of COMT activity on
AKT1 function may be mediated, at least in part. We suggest that
consumption of SAM by COMT may affect the ability of cells to
regulate PS levels involved in translocation and activation of
AKT1 by altering phospholipid methylation, although clearly we
cannot rule out the possibility that the competition of COMT for
SAM impacts on other potential mechanisms (e.g. DNA
Figure 6. Effects of SAM on NRG1-stimulated AKT1 phosphorylation and PS amount in transfected SH-SY5Y cells. (A) Effects of SAM
treatment on NRG1-stimulated Ser-473 phosphorylation of AKT1 in SH-SY5Y cells overexpressing COMT. At 48 hrs after transfection with COMT-GFP,
cells were treated with either 1 mM SAM or vehicle for 60 minutes and stimulated with NRG1a (100 ng/ml). The immunoblot shows a representative
time course of Ser-473 phosphorylation of AKT1and expression of total AKT1 after NRG1a. The bar graph represents the ratio of phosphorylated- to
total AKT1 at 60 min after the stimulation (means6SEM, from 3 transfection experiments). p=0.0413, vehicle vs. SAM treatment. (B) Effects of COMT
transfection on total PS amount in SH-SY5Ycells. SH-SY5Y cells were transfected with COMT-GFP or with control GFP vector. After 48 hrs, cells were
and treated with either 1 mM SAM or vehicle control for 60 min and analyzed to estimate total PS amount of cells by flow cytometry. A graph
indicates PS fluorescence intensity (geometric mean) from two independent transfection experiments. A repeated measure of ANOVA showed
significantly lower PS fluorescence intensity in COMT-transfected cells than that in cells transfected with control vector (*P=0.0087) and a significant
reversal of the transfection effect by SAM treatment (*p=0.0004).
doi:10.1371/journal.pone.0010789.g006
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to changes in PS or independent of such changes and could,
moreover, be the more important mechanism of the effect of
COMT on AKT1 phosphorylation.
As with other chemokine-stimulated migratory responses,
activation of AKT1is essential for NRG1-stimulated cell adhesion
and migration in B lymphoblasts, evidenced by the severe
attenuation of adhesion and migration by PI3K or AKT1
inhibition in these cells [1,2]. Therefore, we suggest that the poor
migratory response we previously showed in Val homozygote
lymphoblasts might be due at least in part to poor activation of
AKT1 in these cells. It is likely that the association between the
COMT Val/Met polymorphism and AKT1 activation is mediated
via its effects on COMT enzyme activity [3], since COMT
overexpression in SH-SY5Y cells significantly decreased NRG1-
induced phosphorylation of AKT1. Taken together, these data
suggest that high COMT activity (resulting either from overex-
pression or as the result of Val homozygosity) is inhibitory to the
function of AKT1.
Identifying the mechanism of how COMT activity inhibits the
function of AKT1, and therefore, NRG-dependent adhesion and
migration is challenging. Considering the well characterized
function of COMT as an enzyme involved in catechol inactivation,
it was conceivable that the effect of COMT on migration and
adhesion could be related to a dopamine- or catecholic estrogen-
mediated mechanism, since these substrates for COMT can be
derived from fetal bovine serum or might be produced by B
lymphoblasts in culture. However, this mechanism is unlikely to be
responsible, since in B lymphoblasts the production of dopamine is
lowand theexpression ofdopamine receptors isscarce(unpublished
observation), and because the migration assay was performed in
serum-free media. Rather, our earlier results suggested another
mechanism, an indirect effect of COMT on methylation of other
critical molecules involved in phospholipids to explain the inverse
relationship between COMT and AKT1 activation.
It has been suggested that an increase in COMT-mediated
methylation decreases the SAM pool and increases SAH, which
acts as a feedback inhibitor of SAM-dependent methylation
processes [4]. Because the Val form of COMT has higher enzyme
activity, it would result in relatively higher SAM consumption and
SAH generation than the Met form, a hypothesis supported by
data showing higher levels of plasma homocysteine, a molecule
formed by the hydrolysis of SAH, in Val carriers compared with
Met homozygotes [39]. Therefore, Val homozygotes would be
predicted to have a greater inhibitory effect of COMT on other
SAM-dependent methyltransferases, compared with Met homo-
zygotes. Among these methyltransferases, we considered phospha-
tidylethanolamine N-methyltransferase (PEMT) to be a good
candidate for mediating COMT’s association with AKT1
function, as it is involved in the synthesis of PS, which is important
Figure 7. Effects of COMT transfection on Ser-473 phosphorylation of AKT1 after stimulation with various ligands in transfected
SH-SY5Y cells. At 48 hrs after transfection, the transfected SH-SY5Y cells were stimulated with NRG1b (100 ng/ml), cannabinoid CB1 agonist ACEA
(14 nM), SDF1b (50 ng/ml) or BDNF (50 ng/ml). The bar graphs represent maximum changes in the ratio of phosphorylated- to total AKT1 during the
60-minutes observation period (means6SEM, from 3–4 transfection experiments per ligand).
doi:10.1371/journal.pone.0010789.g007
Figure 8. Effects of COMT transfection and SAM treatment on
NRG1-stimulated migrataion in SH-SY5Y cells. SH-SY5Y cells were
transfected with COMT-GFP or control vectors (empty GFP) and
cultured in media containing 2%FBS. After 48 hrs, cells were tested
for NRG1-stimulated migration. A graph indicates the chemotaxis index
(mean6 S.E.) from three transfection experiments (n=4–5 per group).
ANOVA showed a significant a SAM treatment effect (p=0.0193) and
transfection-treatment interaction (P=0.0144).
doi:10.1371/journal.pone.0010789.g008
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translocation from the cytoplasm to the plasma membrane,
followed by its phosphorylation at residue T308 and then S473
by PDK1 and PDK2, respectively. It has been well demonstrated
in many systems that translocation of AKT1 is triggered by PIP3
levels, which are regulated by PI3K and PTEN [40]. However, its
translocation has been found to not only require membrane PIP3,
and but also PS [36]. PS serves as an essential attractor for AKT1
by providing a negative charge to the PHD-AKT1. Consistent
with this theory, translocation of AKT1 has been shown to be
affected dose-dependently by PS content [41].
After confirming that PEMT, PSS1 and PSS2, which mediate
the synthesis of PS [37], are expressed in B lymphoblasts
(Supplementary Information, Fig. S5 online), we predicted that
high COMT activity might decrease PS in cells via competition
with PEMT for SAM, especially in serum-free culture, where
exogenous PS, PC and cholines are unavailable. Consistent with
this prediction, we found that overnight culture in serum-free
media caused significant decreases in PS content in B lymphoblasts
and that the extent of the decrease was negatively correlated with
COMT activity. Thus, the higher COMT activity the cells
possessed, the bigger decreases in PS the cells exhibited. We also
showed that NRG1-stimulated translocation of PHD-AKT1 is
significantly lower in Val homozygotes than in Met homozygotes
while NRG1-stimulated production of PIP3 was not reduced in
Val homozygotes compared to Met homozygotes. Therefore, these
results were consistent with the hypothesis that COMT’s effects on
AKT1 are mediated via PS, rather than PIP3. The impaired
NRG1-stimulated PHD-AKT translocation without altering PIP3
generation was observed in COMT-transfected SH-SY5Y cells.
Moreover, the inverse relationship between COMT and PS was
also supported by COMT transfection studies using SH-SY5Y
cells. The transfection studies also demonstrated that the deficit in
AKT1 activation induced by COMT overexpression could be
rescued by SAM administration, demonstrating the SAM-
dependence of COMT’s negative regulation of AKT1 function.
Thus, our results suggest that high COMT activity affects the cells’
ability to maintain or synthesize PS via the PEMT-PSS1 pathway,
leading to reduced PS content and, in turn, poorer translocation
and activation of AKT1.
If the reduction in PS synthesis and AKT1 activation is related
to COMT-mediated SAM consumption, we would expect that
these effects of COMT on AKT1 would not be limited only to
NRG1-ErbB signaling. Consistent with this prediction, studies
using SH-SY5Y and HEK293 cells demonstrated that COMT
overexpression inhibited phosphorylation of AKT1 in other
relevant signaling pathways such as SDF1-CXCR4, and similar
to our findings for NRG1, this inhibition was overcome by SAM
augmentation.
Interestingly, in addition to a single effect of COMT genotype
on AKT1, we also found evidence of an interaction between
COMT Val/Met and a SNP in AKT1 that is associated with
variation in AKT1 protein expression. Thus, the minor A allele of
rs1130233, which is associated with lower AKT1 protein levels in
lymphoblasts, was associated with poorer NRG1-induced AKT1
phosphorylation in cells that also were in COMT Met homozy-
gotes. This statistical interaction is not based on a simple
differential effect of COMT Met and Val alleles on AKT1
phosphorylation in the context of AKT1 genotype, since Val
alleles produced maximum inhibition of NRG1-induced AKT1
phosphorylation regardless of AKT1 genotype. Because AKT1
protein levels would be expected to have an effect on AKT1
recruitment and localization for its activation and because of the
association of rs1130233 genotype with AKT1protein levels [30],
we would expect the effect of the SNP in AKT1 to be more
apparent in Met COMT carriers. Consistent with prior data, we
were able to replicate the association between AKT1 rs1130233
and protein levels [30], demonstrating that the minor A allele of
rs1130233 is associated with low levels of AKT1 protein but not
with changes in AKT1 transcript expression (Supplementary
Information, Fig. S6 online). Thus we suggest that the low levels of
protein in the carriers of the rs1130233 A allele are likely caused by
a post-translational modification, i.e., degradation and turnover
rate of the protein, perhaps related to its association with scaffold
proteins such as 14-3-3 and HSP90 etc [40]. According to the
finding by Harris et al [30], it seems likely that AKT1 rs1130233
itself is not a functional SNP, since its association with AKT1
protein levels is not found in African Americans, who show very
low LD in this genomic region. Therefore they suggested that
another relatively common SNP or combination of SNPs, causes
the post-translational reduction of the protein. However, our
replication of Harris et al’s report confirm that rs1130233 can
serve as a surrogate marker for protein levels in populations with
high LD in this region, such as Caucasians.
Since COMT, AKT1, and ErbB-signaling are each implicated
in both cancer and schizophrenia, NRG1-ErbB signaling in B
lymphoblasts provides a biologically plausible research tool for
elucidating cellular mechanisms relevant to both cancer biology
and neurobiology. Using this system, we demonstrated epistatic
effects of COMT Val/Met and AKT1 rs1130233 on AKT1
activation. The effects were confirmed and some of the potential
mechanisms explored using COMT transfection of cell lines.
Effects of COMT Val/Met in cancer biology have almost always
been discussed in the context of its role in detoxifying carcinogens
and estrogens. Similarly, in neurobiology, the COMT Val/Met
polymorphism has most often been linked with cortical dopamine
metabolism. The present findings offer an additional facet to
COMT’s biology that has new, broad and potentially important
implications for cancer biology and schizophrenia via its
interaction with AKT1 (Supplementary Information, Fig. S7
online). AKT1 signaling mediates a number of critical neuronal
signaling molecular pathways that are implicated in schizophrenia
and also plays a central role in tumorigenesis in many cancers. If
the potential for an AKT1x COMT gene-gene interaction is taken
into consideration in future association studies, we would predict
that the minor A allele of AKT1 rs1130233 might strengthen
associations between COMT Val/Met and the multiple pheno-
types with which it has been associated, including cognitive
function, schizophrenia and cancer. Consistent with this predic-
tion, a recent report highlighted epistatic interactions of COMT
Val/Met and AKT1 rs1130233 on cortical physiology assayed
with neuroimaging and on cognitive functions [31]. Thus, future
studies of epistatic interactions between genes such as COMT and
AKT1 might help in elucidating the relationship between
schizophrenia and cancer that has been discussed in epidemio-
logical studies [42].
Materials and Methods
Subjects
The B lymphoblast cell lines used for this study are derived from
the same subjects described in our previous reports [1,2]. The
subjects are age- and sex-matched and all Caucasians of self-
reported European ancestry to avoid genetic stratification and to
reduce heterogeneity. Importantly, all subjects were selected and
matched on the basis of homozygosity at the catechol-o-
methyltransferase (COMT) Val158Met locus to increase statistical
power to study the biological effects of the COMT Val/Met
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participating in the Clinical Brain Disorders Branch ‘‘Sibling
Study’’ protocol, an ongoing investigation of neurobiological
abnormalities related to genetic risk for schizophrenia. The details
of subject recruitment and examination are described previously
[43]. Blood collection and transformation of lymphocytes were
approved by the NIMH institutional review board, and all donors
provided written informed consent. The number of samples
included in each assay varied based on the availability of cells at
the time of testing.
Genotype determination
Genotypes at rs1130233 (G.A) in AKT1 and rs4680 in COMT
(G.A, val108/158met) were determined by 59 exonuclease allelic
discrimination TaqMan assay using probes and primers available
from ABI as part of their ‘‘Assays on Demand’’ program.
Cell cultures and stimulations
B lymphocytes in a mononuclear cell preparation from the
subjects were transformed by infection with EBV and maintained
as previously described [44]. SH-SY5Y and HEK293 cells were
purchased from the American Tissue Culture Collection (ATCC,
Manassas, VA). The transformed B lymphoblasts, SH-SY5Y and
HEK293 cells were grown in RPMI-1640 medium (Gibco, Grand
Island, NY) containing 15% heat-inactivated fetal bovine serum
(FBS) (Cambrex, Walkersville, MD), L-glutamine (2 mmol/L),
100 mg/mL streptomycin and 100 units/mL penicillin (Gibco) in
an incubator (95% air/5% CO2 at 37uC). For stimulation
experiments, cells were stimulated with 100 ng/ml neuregulin1a
(296–HR) (R & D system, Inc, Minneapolis, MN), which is a 65
amino acid residue recombinant protein from the EGF domain of
NRG1a (aa177–241) For some experiments, cells were stimulated
with 100 ng/ml NRG1b, 50 ng/ml BDNF, 50 ng/ml SDF1b,
50 ng/ml FGFb, or 14 nM arachidonyl-29-chloroethylamide
(ACEA). NRG1b (377-HB), BDNF (248-BD) and SDF1b (351-
FS) were purchased from R & D system, Inc. FGFb (F0291) was
from Sigma-Aldrich Inc, St. Louis, MO. The highly selective CB1
receptor agonist ACEA (1319) was from Tocris (Ellisville, MO).
Immunoblot
Immunoblot and analysis were performed as previously
described [2]. Antibodies to AKT1 (07–416) and phospho-
AKT1 (S473) (05–669) were purchased from Upstate (Charlottes-
ville, VA). An antibody to phospho-AKT1 (S473) (9271) was from
Cell Signaling Technology (Danvers, MA). Anti-phospho-AKT1
(T308) antibody (ab4796) was from Abcam (Cambridge, MA).
Anti-b-actin monoclonal antibody (A5441) was from Sigma (St.
Louis, MO). To detect the primary antibodies, horseradish
peroxidase-conjugated anti-rabbit or mouse IgG antibody (Pierce
Biotechnology, Rockford, IL) was used.
Flow cytometric analysis of cellular phosphatidylserine
levels and PIP3 levels
Relative PS levels at the single cell level were assessed by flow
cytometry after staining both extracellular and intrallular PS with
anti-PS antibody (4B6) (Abcam Inc., Cambridge, MA) using the
Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA). Relative
PIP3 levels were assessed using anti-PIP3 antibody (Echelon
Biosciences Inc., Salt Lake City, UT). Briefly, cells were fixed
with Phosflow Fix Buffer I (BD Bioscience) for 10 min at 37uC.
Cells were then washed with Phosflow Perm/Wash Buffer I (BD
Bioscience), cells permeabilized in Phosflow Perm/Wash Buffer I
were stained with anti-phosphatidylserine antibody (4B6) or biotin-
conjugated anti-PIP3 antibody (Echelon Biosciences Inc.) for 1 hrs
at room temperature. After washing twice with Phosflow Perm/
Wash Buffer I, cells were incubated with phycoerythrin-conjugat-
ed goat anti-mouse IgG antibody (BD Bioscience) to detect 4B6 or
phycoerythrin-conjugated avidin (BD Bioscience) to detect biotin-
conjugated anti-PIP3 antibody. After washing with Phosflow
Perm/Wash Buffer I, cells were analyzed using FACScan (BD
Bioscience). CellQuest software (BD Bioscience) was used to
acquire and quantify the fluorescence signal intensities. To assess
the cells’ PS synthesis ability, we obtained a ratio of geometric
mean fluorescence (GMF) of PS fluorescence in B lymphoblast
after exposure to serum free medium for 24 hrs, over GMF of PS
after culturing in normal culture media containing 15% FBS. To
measure NRG1-stimulated PIP3 production, cells were stimulated
with either NRG1a (100 ng/ml) or vehicle in a 5% CO2 incubator
at 37uC. The reaction was terminated at 0, 5, 10, 15 and 30 min
by fixing cells with Phosflow Fix Buffer I (BD Bioscience) for
10 min at 37uC. Summation of positive and negative changes in
GMF of PIP3 fluorescence over baseline during a 30 min
observation period was calculated to estimate the extent of
NRG1-stimulated PIP3 production.
Overexpression of COMT
Transfection of pAcGFP-N1-COMT (Supplementary Informa-
tion, Method S1 online) was achieved by the use of Lipofectamine
2000 (Invitrogen) in six-well plates or 4-well chamber slides (Nalge
Nunc International, Naperville, IL) according to the manufactur-
er’s recommendation. The cells were transfected at 60%
confluency. Transfection efficiencies generally ranged between
70-80% of cells being transfected, as assessed by GFP expression
under fluorescence microscope. Optimal transfection consistently
resulted in a 4- to 5-fold increase in COMT activity as assessed by
enzyme assay (Supplementary Information, Method S1 online)
and Western blotting of COMT from cell lysates. Cells were left
for 2 days following transfection, before quantification of AKT1
phosphorylation or PS staining.
PHD-AKT translocation assay
Transfection of pDsRed-ph-AKT or pEYFP-ph-AKT (Supple-
mentary Information, Method S1 online) into SH-SY5Y or B
lymphoblasts was achieved using Lipofectamine 2000 (Invitrogen)
in poly-L-lysine coated glass 4-well chamber slides (Nalge Nunc
International) according to the manufacturer’s recommendation.
The AKT1 translocation assay was performed one day after
transfection. The transfected cells were stimulated with NRG1a
(100 ng/ml) for 15 min in an incubator (95% air/5% CO2 at
37uC), fixed with 4% paraformaldehyde and examined under a
Nikon Eclipse E400 fluorescence microscope (Nikon, Japan) or a
LSM 510 confocal laser-scanning microscope (Zeiss, Germany).
The transfected cells in which over 70% of PHD-AKT
fluorescence was located at the plasma membrane were counted
as translocation -positive. Translocation-positive % in stimulated
cells/baseline translocation-positive % in unstimulated cells ratio
was calculated and used as a translocation index in response to the
NRG1 stimulation.
PHD-AKT1 translocation was also examined in COMT-
transfected SH-SY5Y cells in order to determine the effects of
high COMT enzyme activity on AKT1 translocation ability. For
this purpose, the cells were transfected with a combination of two
plasmids, either pDsRed-ph-AKT plus pAcGFP-N1-COMT or
pDsRed-ph-AKT plus control vector. Then AKT1 the transloca-
tion assay was performed 48 hrs after the transfection. The
transfected cells were stimulated with NRG1a (25 ng/ml) for
10 min in an incubator (95% air/5% CO at 37 C), fixed with
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fluorescence microscope. In contrast to B lymphoblasts, SH-SY5Y
cells indicated distinctive patterns of PHD-AKT1 translocation,
which were recognized as multiple spots, clusters or broad
membranous. The changes in proportion of cells with these
patterns before and after NRG1 treatment were measured and
analyzed.
Migration assay using transwell migration methods
The migration assay was carried out using a transwell chamber
with an 8-mm pore size (Costar #3422, Corning, NY). Briefly, cells
were suspended at 4610
5 cells/ml in serum-free RPMI 1640 with
or without 1 mM S-(59-Adenosyl)-L-methionine chloride (A7007
Sigma-Aldrich, St. Louis, MO), Then, 100 ml of the cell
suspension (40,000 cells) were applied to the upper wells of the
transwell chamber and incubated in an incubator (95% air/5%
CO2 at 37uC) for 1 hr. Serum-free RPMI 1640 with or without
NRG1 (0.5 ml/well) was then added to the lower wells. After 4 h
in an incubator (95% air/5% CO2 at 37uC), cells attached to the
lower side of the membrane were detached by dissociation buffer
(Trevigen, Gaithersburg, MD), lysed with 0.1% Triton X-100 and
measured using CyQUANT GR double-stranded DNA detecting
reagent (Molecular Probes, Eugene, Oreg). The results were
expressed as a chemotaxis index calculated by the following
formula: chemotaxis index = migration in response to NRG1/
migration in response to vehicle control (baseline count). All assays
were done in quaduplicate.
Statistical Analysis
Case-control comparisons for allele frequencies were carried out
by chi-square test and Fisher’s exact test. The standard measure of
linkage disequilibrium (LD), denoted as D’ or R
2, was estimated
with Haploview 4.0 in the web http://www.broad.mit.edu/mpg/
haploview. A P value of 0.05 was considered significant in tests for
Hardy-Weinberg equilibrium. Between groups comparisons were
performed by using unpaired t tests, or Wald-Wolfowitz runs test,
where applicable. The effect of genotype was assessed by ANOVA
and followed by Fisher’s post-hoc comparison matrices. The
parametric relationship between the number of target allele and
various phenotypes was assessed using regression analysis. Data
were expressed as mean 6 SEM.
Supporting Information
Figure S1 The genomic structure and locations of SNPs in the
human AKT1 gene. Numbers in parentheses indicate allele
frequencies. Numbers underlined indicate chromosomal positions.
The LD map of the AKT1 region in this study (64 Caucasians) was
obtained through Haploview v 4.0. Pairwise LD is indicated by the
numbers of either D’ (left) or r-square (right) and depth of red
color.
Found at: doi:10.1371/journal.pone.0010789.s001 (0.35 MB TIF)
Figure S2 Effects of COMT Val/Met and AKT1 rs1130233 G/
A (G/G=circle, G/A=triangle) genotypes on NRG1-stimulated
PIP3 production. Methods to estimate NRG1-stimulated PIP3
production are described in the Materials and Methods section.
Found at: doi:10.1371/journal.pone.0010789.s002 (0.03 MB TIF)
Figure S3 Effects of COMT transfection on total PS amount in
HEK293 cells. HEK293 cells were transfected with COMT-GFP
or with control GFP vector and cultured in media containing
2%FBS. After 48 hrs, cells were analyzed to estimate the total
amount of PS by flow cytometry. (A) A two-parameter histogram
represents the expression of PS and transfected GFP. (B) An
overlay histogram represents both external and internal expression
of PS in COMT-transfected cells (filled in black) and control
vector-transfected cells (unfilled) in the gated region (squares in the
two-parameter histograms). (C) The ratio of the proportion of cells
in the upper right quadrant compared to that in the lower right
quadrant in COMT-transfected cells was significantly lower than
in cells transfected with the control vector (P=0.0191). (D) PS
fluorescence intensity in the gated region (squares in the two-
parameters histogram) was significantly decreased in cells
transfected with COMT compared with cells transfected with
control vector (p=0.0319).
Found at: doi:10.1371/journal.pone.0010789.s003 (0.08 MB TIF)
Figure S4 Effects of COMT transfection, S-adenosylhomocys-
teine hydrolase (SAHH) transfection and SAM treatment on total
PS amount in HEK293 cells. HEK293 cells were double-
transfected with COMT-GFP or SAHH-XL5 and their control
vectors (empty GFP or empty XL5, respectively) and cultured in
media containing 2%FBS. After 48 hrs, cells were treated with
1 mM SAM or vehicle for 60 min and analyzed to estimate the
total amount of PS by flow cytometry. A graph indicates the ratio
of the proportion of cells in the upper right quadrant (high PS) to
the lower right quadrant (low PS) in transfected cells. A higher
ratio corresponds to higher total PS. ANOVA showed a significant
COMT transfection effect (p=0.0017) and a SAM treatment
effect (p=0.0192), while there was no effect of SAHH transfection
(p=0.5124) on total PS.
Found at: doi:10.1371/journal.pone.0010789.s004 (0.05 MB TIF)
Figure S5 Expression of PSS1, PSS2 and PEMT in B
lymphoblasts. Phospholipids biosynthetic pathways. PC, phospha-
tidylcholine; PE, phosphatidylethanolamine; PEMT, phosphati-
dylethanolamine N- methyltransferase; PS, phosphatidylserine;
PSS, phosphatidylserine synthase. Agarose gel electrophoresis of
PCR products following RT-PCR for PSS1, PSS2 and PEMT
shows expression of these transcripts in B lymphoblasts. The
amplicons from human brain tissue in the first left lane serve as
positive controls for these amplifications. RT-PCR. Total RNA
was extracted using the SV Total RNA Isolation System
(Promega, Madison, WI) and reverse transcription performed to
generate the first strand of cDNA using a cDNA synthesis kit
(Promega). Synthesized cDNA was then amplified by PCR using
following primer sets. The sequences of primers and the annealing
temperature for PSS1, PSS2 and PEMT amplifications were: 59-
ATGTGATCACCTGGGAGAGG-39 (sense) and 59-CCATTG-
CACAACAGGATGTC-39 (antisense) at 55oC, 59-GGCTCG-
TCTTCTTCGTGAAC-39 (sense) and 59-GATGTAGAAGGG-
CAGGGACA-39 (antisense) at 58oC, 59-AAGACCCGCAAGCT-
GAGCA-39 (sense) and 59-AGTACATGGGGTTGTCCAGGA-
39 (antisense) at 58oC, respectively. The amplification was
performed with negative and positive controls using the optimal
number of cycles to ensure that the amplification was completed
within the exponential range.
Found at: doi:10.1371/journal.pone.0010789.s005 (0.10 MB TIF)
Figure S6 Effects of disease and AKT1 rs1130233 on AKT1
transcripts. It should be noted that, although there were no
differences in AKT1 protein levels or NRG1-stimulated phos-
phorylation between lymphoblasts from patients and controls, two-
way ANOVA showed significant effects of disease on AKT1
mRNA levels (p=0.0263), but no effects of AKT1 rs1130233
(P=0.1514) or no interactions between disease and rs1130233
(p=0.4275). It is unknown whether or not this elevation reflects
compensatory mechanism(s) of unknown defects related to AKT1.
* Y-axis, AKT1 mRNA, qPCR results normalized to the
geometric mean of three house keeping genes. Real-time
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mRNA expression were performed using the TaqMan gene
expression assay system. First-strand cDNA equivalent to 90 ng of
total RNA was prepared in a final volume of 10 ml of Master Mix
(Eurogentec, San Diego, CA) with a validated Taqman primer/
probe mixture specific to the AKT1 gene (Hs00920503_m1)
(Applied Biosystems, Foster City, CA). Real-time RT-PCRs for
three housekeeping genes, GUSB, B2M, and ACTB were also
performed using TaqMan primer-probes Hs99999908_m1,
Hs99999907_m1 and Hs99999903_m1, respectively, to obtain a
geometric mean normalization factor (NF3). Real-time RT-PCR
reactions were performed in triplicate in a 384-well plate using an
ABI Prism 7900 HT sequence detection system. All PCR cycles
comprised 2 min polymerase activation at 50uC followed by
10 min denaturation at 95uC and 40 cycles of 95uC for 15 sec and
60uC for 60 sec. Standard curves were established using a pooled
cDNA stock from 60 individuals. The cycle threshold (Ct) was
determined using SDS 2.0 software (Applied Biosystems). Relative
mRNA level of the AKT1 gene in each sample was expressed as a
Ct ratio to NF3 (the geometric mean of Ct values from three
reference genes) according to the normalization method previously
described by Vandesompele et al 45. 45. Vandesompele, J. et al.
Accurate normalization of real-time quantitative RT-PCR data by
geometric averaging of multiple internal control genes. Genome
biology 3, RESEARCH0034 (2002).
Found at: doi:10.1371/journal.pone.0010789.s006 (0.04 MB TIF)
Figure S7 A hypothetical mechanisms for COMT-mediated
effects on biological functions. The high enzyme activity COMT
Val, whose effects can be enhanced by high concentrations of
substrates, reduces the SAM pool and increases SAH, which acts
as an inhibitor for SAM-dependent methyltransferases. In this
manner, PEMT might be affected by COMT activity. A reduction
of PEMT activity could change the status of phospholipid synthesis
and result in reductions in the PS component of the plasma
membrane, which could affect pleckstrin homology domain-
mediated binding of protein kinases such as AKT1. Therefore,
high COMT could affect not only dopamine or estrogen
metabolism, but also other functions mediated by SAM-dependent
methyltransferases. Reduced AKT1 responses are expected in
individuals with COMT Val than Met homozygotes, as demon-
strated in this study. COMT-mediated effects would also be
expected to be more robust when there are deficits in essential
cofactors such as cholin, B6, B12 and folate and/or when COMT
enzyme substrates e.g., high catechols, steroids and related drugs
are high.
Found at: doi:10.1371/journal.pone.0010789.s007 (0.08 MB TIF)
Method S1 Supplementary Information
Found at: doi:10.1371/journal.pone.0010789.s008 (0.10 MB
PDF)
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